ATE135400T1 - Neue faktor viii polypeptidkoagulantien - Google Patents

Neue faktor viii polypeptidkoagulantien

Info

Publication number
ATE135400T1
ATE135400T1 AT84103630T AT84103630T ATE135400T1 AT E135400 T1 ATE135400 T1 AT E135400T1 AT 84103630 T AT84103630 T AT 84103630T AT 84103630 T AT84103630 T AT 84103630T AT E135400 T1 ATE135400 T1 AT E135400T1
Authority
AT
Austria
Prior art keywords
polypeptides
reacts
factor viii
those
react
Prior art date
Application number
AT84103630T
Other languages
English (en)
Inventor
Theodore S Zimmerman
Carol A Fulcher
Original Assignee
Scripps Research Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27046849&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE135400(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Scripps Research Inst filed Critical Scripps Research Inst
Application granted granted Critical
Publication of ATE135400T1 publication Critical patent/ATE135400T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Separation Of Suspended Particles By Flocculating Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT84103630T 1983-03-31 1984-04-02 Neue faktor viii polypeptidkoagulantien ATE135400T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US48110583A 1983-03-31 1983-03-31
US55650883A 1983-11-30 1983-11-30

Publications (1)

Publication Number Publication Date
ATE135400T1 true ATE135400T1 (de) 1996-03-15

Family

ID=27046849

Family Applications (2)

Application Number Title Priority Date Filing Date
AT93108007T ATE155490T1 (de) 1983-03-31 1984-04-02 Monoklonale antikörper gegen neue faktor-viii gerinnungspolypeptide
AT84103630T ATE135400T1 (de) 1983-03-31 1984-04-02 Neue faktor viii polypeptidkoagulantien

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT93108007T ATE155490T1 (de) 1983-03-31 1984-04-02 Monoklonale antikörper gegen neue faktor-viii gerinnungspolypeptide

Country Status (12)

Country Link
EP (3) EP0561427B1 (de)
JP (2) JPH0829089B2 (de)
AT (2) ATE155490T1 (de)
AU (1) AU572128B2 (de)
CA (1) CA1341506C (de)
DE (2) DE3486423T3 (de)
DK (2) DK172036B1 (de)
FI (1) FI841281A (de)
IE (2) IE80638B1 (de)
NO (1) NO167533C (de)
SG (2) SG49675A1 (de)
ZA (1) ZA842418B (de)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4657894A (en) * 1983-03-31 1987-04-14 Scripps Clinic & Research Foundation New factor VIII coagulant polypeptides
EP1006182A3 (de) * 1984-01-12 2000-06-14 Chiron Corporation Polypeptidfragmente des Faktors-VIIIc, zu den entsprechenden Sonden und DNA-Sequenzen und DNA-Konstruktionen
US5045455A (en) * 1984-01-12 1991-09-03 Chiron Corporation Factor VIII:C cDNA cloning and expression
US5004804A (en) * 1984-01-12 1991-04-02 Nordisk Gentofte Method and composition for preparation of factor VIIIC
EP0432134A1 (de) * 1984-01-12 1991-06-12 Chiron Corporation Hybridom-Zellinien und monoklonale Antikörper
US4716117A (en) * 1984-10-26 1987-12-29 Chiron Corporation Monoclonal antibodies to factor VIIIC
US7138505B1 (en) 1984-01-12 2006-11-21 Novartis Vaccines And Diagnostics, Inc. Factor VIII:C nucleic acid molecules
FI86885C (fi) * 1984-04-20 1992-10-26 Genentech Inc Foerfarande foer framstaellning av human rekombinantfaktor viii och nukleinsyrasekvenser och vektorer anvaend daertill
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
SE8501050D0 (sv) * 1985-03-05 1985-03-05 Kabivitrum Ab Biologically active fragments of human antihemophilic factor and method for preparation thereof
KR910006424B1 (ko) * 1985-08-21 1991-08-24 인코텍스 비.브이 편성브리프(brief) 제조방법
JP2593500B2 (ja) * 1986-06-24 1997-03-26 ノルデイスク ゲントフテ エー／エス ▲ｖｉｉｉ▼因子フラグメントの凝固活性複合物の製造方法
CA1339946C (en) * 1987-03-31 1998-07-07 Michael J. Griffith Ultrapurification process for polypeptides
EP0690126B1 (de) 1987-06-12 2001-11-28 Baxter Aktiengesellschaft Proteine mit Faktor VIII Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende Zusammensetzungen
IL88309A0 (en) * 1987-11-17 1989-06-30 Scripps Clinic Res Peptides for use in the purification of factor viii
FR2662166A1 (fr) * 1990-05-18 1991-11-22 Fondation Nale Transfusion San Procede de preparation de facteur viii de tres haute purete comprenant une etape rapide d'immunoadsorption.
AU7254894A (en) * 1993-07-23 1995-02-20 Baxter International Inc. Activated human factor viii and method of preparation
US5576291A (en) * 1993-09-13 1996-11-19 Baxter International Inc. Activated factor VIII as a therapeutic agent and method of treating factor VIII deficiency
PL198123B1 (pl) 1999-02-22 2008-05-30 Baxter Int Kompozycja czynnika VIII bez dodatku albuminy i jej zastosowanie
WO2003013244A1 (en) 2001-08-03 2003-02-20 The Government Of The United State Of America, As Represented By The Secretary Of The Department Of Health And Human Services Oral treatment of hemophilia
CA2742328C (en) 2008-11-07 2019-02-26 Baxter International Inc. Factor viii formulations
BRPI1105317A2 (pt) 2011-01-24 2013-04-30 Fundacco Hemoct De Ribeirco Preto produÇço estÁvel e em larga escala de fviii humano em linhagem celular humana sk-hep-1

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4364937A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human T cell antigen and methods of preparing same
US4364936A (en) * 1980-01-08 1982-12-21 Ortho Pharmaceutical Corporation Monoclonal antibody to a human monocyte antigen and methods of preparing same
US4361509A (en) * 1981-12-14 1982-11-30 Scripps Clinic And Research Foundation Ultrapurification of factor VIII using monoclonal antibodies
US4397841A (en) * 1982-06-28 1983-08-09 Monsanto Company Production of blood coagulation factor VIII:C

Also Published As

Publication number Publication date
EP0123945B2 (de) 2000-04-19
JPH0638790A (ja) 1994-02-15
AU2627284A (en) 1984-10-04
JPH0829089B2 (ja) 1996-03-27
NO167533C (no) 1991-11-13
DK174984A (da) 1984-10-01
EP0123945A1 (de) 1984-11-07
EP0561427B1 (de) 1997-07-16
NO841277L (no) 1984-10-01
SG49675A1 (en) 1998-06-15
DE3486423T2 (de) 1996-09-19
ZA842418B (en) 1984-11-28
SG48229A1 (en) 1998-04-17
DE3486423T3 (de) 2001-02-08
EP0123945B1 (de) 1996-03-13
DK172036B1 (da) 1997-09-22
AU572128B2 (en) 1988-05-05
DE3486423D1 (de) 1996-04-18
JPS59184130A (ja) 1984-10-19
IE80858B1 (en) 1999-04-21
IE80638B1 (en) 1998-10-21
CA1341506C (en) 2006-06-06
EP0561427A1 (de) 1993-09-22
FI841281A0 (fi) 1984-03-30
EP0770396A2 (de) 1997-05-02
DK50497A (da) 1997-05-02
IE840788L (en) 1984-09-30
DK174984D0 (da) 1984-03-30
DE3486453T2 (de) 1998-02-26
IE960783L (en) 1984-09-30
DE3486453D1 (de) 1997-08-21
EP0770396A3 (de) 1997-07-23
FI841281A (fi) 1984-10-01
NO167533B (no) 1991-08-05
ATE155490T1 (de) 1997-08-15

Similar Documents

Publication Publication Date Title
DE3486423D1 (de) Neue Faktor VIII Polypeptidkoagulantien
FR2715664B1 (fr) Baculovirus recombinant et son utilisation pour la production d'anticorps monoclonaux.
IL73883A (en) Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha
NL300023I1 (nl) Chimerische immuunglobulinen met specificiteit voor p55-TAC-eiwit van de IL-2-receptor.
EP0212403A3 (de) Monoklonale Antikörper gegen mucinartige Differenzierungsantigene des Menschen
DE68925226D1 (de) Monoklonale Antikörper
CA2074089A1 (en) Extracellular segments of human e immunoglobulin anchoring peptides and antibodies specific therefor
ATE110084T1 (de) Anticytomegaloviraler menschlicher monoklonaler antikörper und dessen herstellung.
DE3581288D1 (de) Antileishmania monoklonale antikoerper, diese antikoerper ausscheidende hybridomas, von diesen antikoerpern erkannte leishmaniaantigene, verfahren zur herstellung und verwendung von diesen monoklonalen antikoerpern und antigenen.
JPS568355A (en) Selective formation of disulfide bridge in polypeptide
DE3582358D1 (de) Monoklonaler antikoerper und verfahren zur quantitativen bestimmung von immunoglobulinen mittels dieses antikoerpers.
ATA111789A (de) Humaner monoklonaler antikörper und hybridom zur herstellung desselben
DE3581336D1 (de) Polypeptid verwandt mit alpha-hanp.
DE3580382D1 (de) Monoklonale antikoerper gegen alpha-2 interferon und hybridomas, die solche antikoerper produzieren.
ES8505409A1 (es) Procedimiento para purificar interferon de humano
KR870004137A (ko) 항인간 인터로이킨 1항체(Anti Hunam Interleukin 1 Antibody)와 그의 제법 및 그의 사용법
DK105085D0 (da) Monoklonalt antistof samt hybridom-cellelinie, der udskiller dette
DE3484456D1 (de) Monoklonale antikoerper.
NZ228194A (en) Monoclonal antibodies which bind to the n-terminal peptide sequence of the betasubunit of human haemoglobiin
BG46674A1 (en) Hybridom cell line mus musculus vsp- 1e7 secreting monoclonal antibodies against virus of classical plague
ATE55414T1 (de) Polypeptid und polypeptidzusammensetzung.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
UEP Publication of translation of european patent specification
EELA Cancelled due to lapse of time